trending Market Intelligence /marketintelligence/en/news-insights/trending/wlpjsu3tlywmlkmdhevfka2 content esgSubNav
In This List

Cutera's nonsurgical fat removal system gets US FDA clearance for expanded use

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Cutera's nonsurgical fat removal system gets US FDA clearance for expanded use

The U.S. Food and Drug Administration cleared Cutera Inc.'s nonsurgical body sculpting system truSculpt 3D for lipolysis, or the breakdown of fat.

The device previously has FDA clearance for the reduction of fat without surgery.

Brisbane, Calif.-based Cutera is a medical device company that designs, develops, manufactures, markets and services laser and other energy-based aesthetics systems worldwide.